FFAR2 and graft versus host disease: Once again, allogeneic B6 Gpr43−/− animals demonstrated more severe GVHD than WT mice (Fig. 1m, n, P < 0.001) confirming that GPR43 expression in hosts mitigates predominantly GI GVHD.